ABSTRACT NUMBER: ESOC2026LT81 VALIDATION OF A TRUSTWORTHY AI-BASED CLINICAL DECISION SUPPORT SYSTEM FOR PREDICTING PATIENT OUTCOME IN ACUTE STROKE TREATMENT (VALIDATE)

Abstract Background and aims Artificial intelligence(AI)-based clinical decision support systems(CDSS) can rapidly analyze patient data to support clinical decision-making. Although acute ischemic stroke(AIS) reperfusion treatments benefits are established, using individualized outcome predictions for hyperacute treatment decisions remains challenging. We aimed to test the VALIDATE-CDSS providing real-time, individualized outcome predictions to support treatment selection in AIS. Methods Prospective non-interventional time-motion study of consecutive AIS at three tertiary centers. A shadow researcher collected real-time data via mobile application; clinicians remainded blinded to predictions. For each patient, 3 outcome predictions were locally generated:clinical data alone, +non-contrast CT, and +CT angiography. The system predicts 3-month modified Rankin Scale(mRS) for four treatments: intravenous thrombolysis (IVT), mechanical thrombectomy(EVT), combined IVT+EVT, or no reperfusion(NoREP). Primary outcome: feasibility and usability of VALIDATE-CDSS in real-world hyperacute stroke care. Secondary outcomes: predictive accuracy, treatment concordance, and performance across subgroups. Results 290 AIS patients (53% men, median NIHSS 4[1-12]) were enrolled over 17 months, representing 38% of eligible office-hour strokes. Treatments received: 16.2% IVT, 21.4% EVT, 15.5% both, 46.9% NoREP. All patients had ≥1 prediction; 62.2% had all three. VALIDATE-CDSS achieved excellent System Usability Scale score (82.1/100). However, challenges emerged regarding real-time integration, moderate clinician confidence in predictions, and visualization comprehension. In 28% of cases, neurologists agreed with predictions; only 9% would have changed treatment according to results. Secondary outcomes are being analyzed now. Conclusions AI-based CDSS application in hyperacute stroke is feasible, achieving excellent usability despite challenges in real-time integration and user confidence. Conflict of interest

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1959
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026LT81 VALIDATION OF A TRUSTWORTHY AI-BASED CLINICAL DECISION SUPPORT SYSTEM FOR PREDICTING PATIENT OUTCOME IN ACUTE STROKE TREATMENT (VALIDATE)

Adam Hilbert, Victòria Sala, Dietmar Frey, Ingo Werren et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026LT81 VALIDATION OF A TRUSTWORTHY AI-BASED CLINICAL DECISION SUPPORT SYSTEM FOR PREDICTING PATIENT OUTCOME IN ACUTE STROKE TREATMENT (VALIDATE)

Adam Hilbert, Victòria Sala, Dietmar Frey, Ingo Werren, Mercedes Ayesta, Marta Rubiera, Thi Nguyet Nguyen, Luis Lopez-Ramos, Martin Bendszus, Ronen R Leker
article en

Abstract

Abstract Background and aims Artificial intelligence(AI)-based clinical decision support systems(CDSS) can rapidly analyze patient data to support clinical decision-making. Although acute ischemic stroke(AIS) reperfusion treatments benefits are established, using individualized outcome predictions for hyperacute treatment decisions remains challenging. We aimed to test the VALIDATE-CDSS providing real-time, individualized outcome predictions to support treatment selection in AIS. Methods Prospective non-interventional time-motion study of consecutive AIS at three tertiary centers. A shadow researcher collected real-time data via mobile application; clinicians remainded blinded to predictions. For each patient, 3 outcome predictions were locally generated:clinical data alone, +non-contrast CT, and +CT angiography. The system predicts 3-month modified Rankin Scale(mRS) for four treatments: intravenous thrombolysis (IVT), mechanical thrombectomy(EVT), combined IVT+EVT, or no reperfusion(NoREP). Primary outcome: feasibility and usability of VALIDATE-CDSS in real-world hyperacute stroke care. Secondary outcomes: predictive accuracy, treatment concordance, and performance across subgroups. Results 290 AIS patients (53% men, median NIHSS 4[1-12]) were enrolled over 17 months, representing 38% of eligible office-hour strokes. Treatments received: 16.2% IVT, 21.4% EVT, 15.5% both, 46.9% NoREP. All patients had ≥1 prediction; 62.2% had all three. VALIDATE-CDSS achieved excellent System Usability Scale score (82.1/100). However, challenges emerged regarding real-time integration, moderate clinician confidence in predictions, and visualization comprehension. In 28% of cases, neurologists agreed with predictions; only 9% would have changed treatment according to results. Secondary outcomes are being analyzed now. Conclusions AI-based CDSS application in hyperacute stroke is feasible, achieving excellent usability despite challenges in real-time integration and user confidence. Conflict of interest

European Stroke JournalVol. 11(Supplement_1)
Heidelberg University (DE), Hadassah Medical Center (IL), Ibero-American Institute (DE), University Hospital Heidelberg (DE), University Medical Center (US), Vall d'Hebron Institut de Recerca (ES), Technological University Dublin (IE), Simula Metropolitan Center for Digital Engineering (NO), Median SCP (Spain) (ES), Charité - Universitätsmedizin Berlin (DE)
Peace, Justice and strong institutions
Openalex Percentile: Top 9%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.